Growth Metrics

Adagio Medical Holdings (ADGM) Depreciation & Amortization (CF) (2023 - 2026)

Adagio Medical Holdings has reported Depreciation & Amortization (CF) over the past 4 years, most recently at $210000.0 for Q1 2026.

  • Quarterly Depreciation & Amortization (CF) fell 22.51% to $210000.0 in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $1.1 million through Mar 2026, up 27.02% year-over-year, with the annual reading at $970000.0 for FY2025, 31.08% up from the prior year.
  • Depreciation & Amortization (CF) was $210000.0 for Q1 2026 at Adagio Medical Holdings, down from $237000.0 in the prior quarter.
  • Over five years, Depreciation & Amortization (CF) peaked at $500000.0 in Q3 2025 and troughed at $100000.0 in Q3 2023.
  • The 4-year median for Depreciation & Amortization (CF) is $254000.0 (2025), against an average of $261300.0.
  • Year-over-year, Depreciation & Amortization (CF) soared 216.0% in 2024 and then plummeted 36.71% in 2025.
  • A 4-year view of Depreciation & Amortization (CF) shows it stood at $133000.0 in 2023, then skyrocketed by 137.59% to $316000.0 in 2024, then fell by 25.0% to $237000.0 in 2025, then decreased by 11.39% to $210000.0 in 2026.
  • Per Business Quant, the three most recent readings for ADGM's Depreciation & Amortization (CF) are $210000.0 (Q1 2026), $237000.0 (Q4 2025), and $500000.0 (Q3 2025).